The Review Index
37 provider and product profiles, with sources, offer breakdowns, and custom charts.
Find a provider by name or care category, then use its offer data to compare the actual purchase.
- Provider profiles
- 33
Programs and platforms with distinct service and billing models.
- Medicine profiles
- 2
Wegovy and Zepbound explain product evidence, not clinic services.
- Review total
- 35
The current editorial inventory; not a count of recommended treatments.
37 of 37 reviews
CoreAge Rx
A stated monthly compounded-medicine price, with important prescription and refund checkpoints.
$79/moRead the research →Compounded semaglutide or tirzepatideSuperHealthy Rx
A current-source review of SuperHealthy Rx GLP-1 care: a written plan that can be compared fairly, billing questions and evidence limits.
$85/mo semaglutide offerRead the research →Compounded semaglutide or tirzepatideLikeness Rx
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
From $79/mo equivalentRead the research →Plan-specific billingNoom Med
A program with several treatment and billing tracks; identify your exact plan before comparing the headline.
Plan variesRead the research →Introductory membershipRo
Ro separates the cost of its care membership from the prescription cost.
$39 startRead the research →Insurance, cash pay or compounded planFound
Found offers more than one treatment and payment pathway, so a personalized quote is essential.
Plan variesRead the research →Membership onlyMochi Health
Mochi’s recurring membership and medicine charges need to be read together.
$79/moRead the research →Compounded plansRemedyMeds
A compounded-treatment program where the current quote matters more than a general promotional headline.
See quoteRead the research →Offer may changeLevelsRx
A promotional starting price with different figures across the public offer; confirm the enrolled plan.
$88/moRead the research →Treatment-specificDirectMeds
DirectMeds needs a treatment-specific quote; the homepage does not support one universal injection price.
See quoteRead the research →Plan-specificMEDVi
A heavily marketed online offer that should be evaluated through the exact plan and clinical process.
See quoteRead the research →Introductory membershipHers
Hers combines a care membership with a separate medication cost; the introductory rate is not the whole bill.
$39 startRead the research →Plan-specificLifeMD
LifeMD’s full quote should connect the clinical program, medicine, and any additional expenses.
See quoteRead the research →Term-based membershipWeightWatchers Clinic
A familiar behavior-support platform with a separate clinical membership and prescription expense.
Dated $25Read the research →Compounded optionsWellMedr
Formulation details deserve special attention when an offer combines a GLP-1 ingredient with added substances.
See quoteRead the research →Plan-specificEden
Eden has several treatment offers; distinguish the introductory promotion from the actual renewal.
See quoteRead the research →Care membershipIvím Health
Ivím’s advertised membership should be paired with the treatment quote before assessing the total cost.
$75/moRead the research →Treatment-specific planHenry
Henry describes bundled provider visits, medication and supplies; monthly flexibility needs to be distinguished from the balance on a longer plan.
See quoteRead the research →Treatment-specificTrimRx
TrimRx advertises starting offers, but its official pages do not consistently tie the lowest figure to one medicine format.
$179 startRead the research →Treatment-specificGala Health
Gala describes clinician review and continuing support; its displayed outcome graph models underlying trial evidence rather than Gala patient results.
See quoteRead the research →Offer-specificAltRx
AltRx’s low starting GLP-1 rate sits alongside different compounded and branded offers; paid testimonials and complete plan terms need their own reading.
$89/moRead the research →Consultation onlyPlushCare
PlushCare’s $129 self-pay initial visit is a consultation price; membership, medicines and laboratory costs are separate parts of the comparison.
$129 visitRead the research →Plan-specificFuturHealth
FuturHealth combines a platform, nutrition features and access to medical professionals; its program comparison and complete current quote need careful qualification.
See quoteRead the research →Treatment-specificReflexMD
ReflexMD describes separate physician and wellness-advisor roles, with medication conditional on review; price and continuing subscription terms remain unresolved.
See quoteRead the research →Plan-specificG-Plans
G-Plans combines clinical access and nutrition tools; its weight-loss illustration refers to branded trials rather than a measured G-Plans cohort.
See quoteRead the research →Plan-specificFridays
Fridays’ buy-three-get-one promotion is a discounted four-month membership bill, not a separate free shipment; medication and renewal details need their own scope.
See quoteRead the research →Treatment-specificShed
Shed advertises compounded semaglutide from $159 and a conditional 120-day guarantee; its wider wellness catalogue and outcome headlines are separate records.
$159/moRead the research →Treatment-specificBrightmeds
Brightmeds describes an all-in-one offer but separates its platform from medical and pharmacy care; the exact quote and dispensing preparation remain important.
See quoteRead the research →Introductory offerEnhance.MD
Enhance.MD’s introductory offer needs its continuing charge and supply period; combined-drug marketing is not approval or superiority evidence.
$112 startRead the research →Offer-specificSnagRx
SnagRx advertises low flat monthly prices, but longer subscription terms and its medically limited refund rule qualify the cancellation headline.
$69/moRead the research →Treatment-specificBetterMe Rx
BetterMe Rx separates its telehealth platform from prescribing and pharmacy dispensing; the first-order discount does not reveal the complete continuing price.
See quoteRead the research →Branded medicineWegovy
Wegovy is a branded semaglutide medicine record, not a clinic; its current forms, indications and savings terms must remain distinct from a provider’s package.
Offer variesRead the research →Branded medicineZepbound
Zepbound’s manufacturer record identifies tirzepatide, weight-management and specific sleep-apnea uses; savings routes and care access are separate from the medicine itself.
Offer variesRead the research →Compounded planTrimi
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
$99/mo equiv.Read the research →Compounded planEmbody
Embody advertises low starting prices and no membership fee, while its FAQ ties the actual rate to the selected plan length and defines cancellation around shipment processing.
$69/moRead the research →Compounded injection programCareBox
CareBox’s product headlines need a selected-plan invoice; its refund policy distinguishes early cancellation, clinical disqualification and unshipped prepaid months.
Advertised starts: $69 semaglutide / $119 tirzepatideRead the research →Prepaid compounded injection plansHe & She MD
He & She MD publishes three-, six- and twelve-month totals, but its linked membership terms do not clearly resolve the cancellation treatment of those specific packages.
Semaglutide $447 / 3 months, $834 / 6 months or $1,188 annuallyRead the research →A directory with different kinds of entries
A guide to this publication and the records behind a decision
- Provider profiles33
Programs and platforms with distinct service and billing models.
- Medicine profiles2
Wegovy and Zepbound explain product evidence, not clinic services.
- Review total35
The current editorial inventory; not a count of recommended treatments.
Use the source documents and your selected agreement. A public description does not determine personal treatment eligibility.
View the printable chart image
How to use the filters
The review search matches names, care descriptions and summaries. The category filter narrows the directory without turning it into a clinical recommendation. A provider can appear in more than one category because its catalogue may include several treatment paths.
Open the research summary to identify the most useful unanswered question, then follow the chart’s sources. The prices on the directory cards are starting points with different scopes. Use the full review to distinguish membership, medicine, promotion and commitment.
Questions worth answering
Where can I report a problem with this page?
Use the contact page and include the affected URL and a public source or a description of the website problem. Do not send sensitive medical or payment records to the editorial inbox.
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
- Injection Index — comparison method ↗Publication method ·
- Enhance.MD cards — November 13 observation ↗Dated provider observation ·
- Med+ terms — November 13 observation ↗Dated provider observation ·